Akums launches generic formulation to treat migraine
时间:2024-06-26 06:52:14 阅读(143)
Akums Drugs & Pharmaceuticals Ltd., a contract manufacturing pharmaceutical company, on Friday announced that it has launched the Lasmiditan tablet which is prescribed to treat migraine. This medication has received approvals from the Drug Controller General of India (DCGI) and the United States Food and Drug Administration (USFDA).
It is the generic formulation of Eli Lilly’s REYVOW which is indicated for treatment of acute migraine.
In a 2019 report, it was revealed that headache disorders, including both migraines and tension-type headaches, have emerged as the most prevalent neurological conditions in India, affecting an astonishing 488 million individuals.
The International Headache Society (IHS) outlines criteria for diagnosing migraine, including specific characteristics and associated symptoms observed in at least five attacks. Two main subtypes, migraine without aura and migraine with aura, present distinct features, with the latter involving focal neurological symptoms preceding or accompanying the headache.
“Migraine poses a significant global impact. According to a 2019 report, headache disorders, encompassing migraine and tension-type headaches, emerged as the most widespread neurological conditions in India, impacting a staggering 488 million individuals. Despite this substantial prevalence and the resulting disability, migraine awareness among patients remains inadequate. Compounded by frequent misdiagnosis as other headache disorders, these factors contribute to an increased burden associated with migraine. In light of this, Akums aims to provide a solution for managing this condition with the introduction of the Lasmiditan tablet,” Sanjeev Jain, Joint Managing Director, Akums Drugs & Pharmaceuticals Ltd., said.
上一篇:RBI intervening in forex market to cushion Rupee fall; spends $82
下一篇:Will Nifty rise or fall below 18,600- See SGX Nifty, FII data, US shares, more before market opens
猜你喜欢
- Yes Bank to issue securities worth Rs 8,898 crore to Carlyle, Advent
- CBSE Practical Exam 2024- Guidelines released for class 10 and 12
- RBI asks banks to periodically launch special drive to locate customers, reduce unclaimed deposits
- RBL Bank, Airtel, Axis Bank, L&T, Dr Reddy’s Labs among 148 stocks that hit 52-week highs; 9 touch 52-week lows
- Chhattisgarh makes Ayodhya pilgrimage easy! Annual free train travel for Ram temple darshan
- Realme 11 Pro Plus 5G- 10 things to know before you buy
- Buy these two stocks for near term gains as Nifty gears up to claim fresh all-time highs
- RIL Results Highlights- Reliance net profit up 22
- Republic Day 2023- President Droupadi Murmu, PM Modi welcome Egyptian president at Rashtrapati Bhavan – See Photos